UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
NetEase
NTES
|
+$383M |
| 2 |
AbbVie
ABBV
|
+$262M |
| 3 |
VMW
VMware, Inc
VMW
|
+$183M |
| 4 |
Aptiv
APTV
|
+$175M |
| 5 |
T-Mobile US
TMUS
|
+$170M |
Top Sells
| 1 |
Alibaba
BABA
|
+$591M |
| 2 |
Microsoft
MSFT
|
+$567M |
| 3 |
Apple
AAPL
|
+$464M |
| 4 |
Amazon
AMZN
|
+$268M |
| 5 |
Abbott
ABT
|
+$266M |
Sector Composition
| 1 | Technology | 22.77% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 13.53% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Gossamer Bio
GOSS
$707M
| $560K | ﹤0.01% |
43,052
+31,852
| +284% | +$414K |
|
2027
Tompkins Financial
TMP
$998M
| $557K | ﹤0.01% |
8,600
-1,249
| -13% | -$80.9K |
|
2028
Preferred Bank
PFBC
$1.17B
| $557K | ﹤0.01% |
12,992
+634
| +5% | +$27.2K |
|
|
CMO
2029
DELISTED
Capstead Mortgage Corp.
CMO
| $556K | ﹤0.01% |
101,257
-16,570
| -14% | -$91K |
|
2030
StoneX
SNEX
$5.02B
| $555K | ﹤0.01% |
22,698
-2,662
| -10% | -$65.1K |
|
|
WIRE
2031
DELISTED
Encore Wire Corp
WIRE
| $555K | ﹤0.01% |
11,365
+3,799
| +50% | +$185K |
|
2032
HealthStream
HSTM
$839M
| $553K | ﹤0.01% |
24,971
+5,231
| +26% | +$116K |
|
|
ENDP
2033
DELISTED
Endo International plc
ENDP
| $551K | ﹤0.01% |
160,775
-20,455
| -11% | -$70.2K |
|
2034
W&T Offshore
WTI
$261M
| $551K | ﹤0.01% |
241,854
+63,733
| +36% | +$145K |
|
2035
Pathward Financial
CASH
$1.74B
| $551K | ﹤0.01% |
30,320
-2,141
| -7% | -$38.9K |
|
2036
Evolent Health
EVH
$1.07B
| $550K | ﹤0.01% |
77,198
+8,566
| +12% | +$61K |
|
|
KNL
2037
DELISTED
Knoll, Inc.
KNL
| $550K | ﹤0.01% |
45,089
-9,043
| -17% | -$110K |
|
|
POLY
2038
DELISTED
Plantronics, Inc.
POLY
| $548K | ﹤0.01% |
37,354
+3,830
| +11% | +$56.2K |
|
2039
The Bancorp
TBBK
$3.5B
| $548K | ﹤0.01% |
55,880
-4,644
| -8% | -$45.5K |
|
2040
Vanda Pharmaceuticals
VNDA
$265M
| $547K | ﹤0.01% |
47,850
+2,814
| +6% | +$32.2K |
|
|
LGF.A
2041
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $547K | ﹤0.01% |
73,847
+5,679
| +8% | +$42.1K |
|
2042
Standex International
SXI
$2.44B
| $547K | ﹤0.01% |
9,497
+4,523
| +91% | +$260K |
|
2043
CTS Corp
CTS
$1.22B
| $546K | ﹤0.01% |
27,267
+318
| +1% | +$6.37K |
|
2044
Generation Bio
GBIO
$40.3M
| $546K | ﹤0.01% |
+2,600
| New | +$546K |
|
2045
Amneal Pharmaceuticals
AMRX
$3.08B
| $545K | ﹤0.01% |
114,514
-2,214
| -2% | -$10.5K |
|
|
FLXN
2046
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $545K | ﹤0.01% |
41,432
+4,513
| +12% | +$59.3K |
|
2047
CorVel
CRVL
$4.39B
| $545K | ﹤0.01% |
23,052
+8,742
| +61% | +$207K |
|
|
TCDA
2048
DELISTED
Tricida, Inc. Common Stock
TCDA
| $544K | ﹤0.01% |
+19,791
| New | +$544K |
|
2049
Phreesia
PHR
$1.52B
| $542K | ﹤0.01% |
+19,175
| New | +$542K |
|
2050
St. Joe Company
JOE
$2.91B
| $542K | ﹤0.01% |
27,909
-10,251
| -27% | -$199K |
|